Rocket Pharmaceuticals, Inc. (RCKT)

NASDAQ: RCKT · Real-Time Price · USD

2.300

-0.090 (-3.77%)

At close: Nov 13, 2026, 4:00 PM EST

2.280

-0.020 (-0.87%)

After-hours: Nov 13, 2026, 7:30 PM EST

Rocket Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	95.47	77.56	163.64	55.9	140.52	232.69
Short-Term Investments	174.04	111.37	208.7	317.27	215.88	156.05
Cash & Short-Term Investments	269.51	188.93	372.34	373.18	356.39	388.74
Cash Growth	20.99%	-49.26%	-0.22%	4.71%	-8.32%	-19.47%
Prepaid Expenses	8.15	3.81	5.85	5.05	7.67	3.32
Total Current Assets	278.05	192.73	378.18	378.22	364.06	392.06
Property, Plant & Equipment	65.39	71.59	83.32	87.59	77.65	72.35
Long-Term Investments	9.93	-	-	34.32	43.28	-
Goodwill	39.15	39.15	39.15	39.15	39.15	30.82
Other Intangible Assets	25.15	25.15	25.15	25.15	25.72	-
Other Long-Term Assets	1.82	1.82	1.89	1.91	1.95	1.8
Total Assets	419.5	330.45	527.7	566.34	551.81	497.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.47	2.33	1.63	1.77	2.27	0.48
Accrued Expenses	23.2	24.91	36.02	29.8	30.54	17.81
Current Portion of Leases	2.91	2.92	2.86	2.72	2.51	2.55
Current Unearned Revenue	-	-	-	-	0.6	0.6
Other Current Liabilities	0.07	0.05	0.19	14.21	3.25	0.73
Total Current Liabilities	38.32	30.21	40.68	48.51	39.17	22.17
Long-Term Debt	30.43	-	-	-	-	-
Long-Term Leases	21.7	21.96	22.64	22.33	20.36	20.05
Other Long-Term Liabilities	2.33	1.06	1.14	2.94	2.6	0.08
Total Liabilities	92.78	53.23	64.47	73.77	62.12	42.3

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1.11	1.08	1.07	0.9	0.79	0.65
Additional Paid-In Capital	1,741	1,717	1,680	1,451	1,203	946.15
Retained Earnings	-1,415	-1,441	-1,218	-959.37	-713.78	-491.91
Treasury Stock	-	-	-	-	-0.05	-
Comprehensive Income & Other	-0.39	-0.03	0.07	0.32	-0.36	-0.16
Total Common Equity	326.72	277.22	463.23	492.57	489.69	454.72
Shareholders' Equity	326.72	277.22	463.23	492.57	489.69	454.72
Total Liabilities & Equity	419.5	330.45	527.7	566.34	551.81	497.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	55.04	24.88	25.5	25.04	22.87	22.6
Net Cash (Debt)	214.47	164.05	346.84	348.13	333.53	366.14
Net Cash Growth	8.48%	-52.70%	-0.37%	4.38%	-8.91%	-13.04%
Net Cash Per Share	1.90	1.48	3.66	4.14	4.89	5.79
Filing Date Shares Outstanding	111.66	108.57	106.63	90.5	79.35	64.51
Total Common Shares Outstanding	111.39	108.32	106.45	90.28	79.12	64.51
Working Capital	239.73	162.53	337.5	329.72	324.89	369.89
Book Value Per Share	2.93	2.56	4.35	5.46	6.19	7.05
Tangible Book Value	262.42	212.92	398.93	428.27	424.81	423.91
Tangible Book Value Per Share	2.36	1.97	3.75	4.74	5.37	6.57
Machinery	48.32	48.06	48.85	44.58	35.61	25.21
Leasehold Improvements	7.33	7.33	7.28	6.72	0.59	0.41

SEC Filings: 10-K · 10-Q